Biological agents for severe asthma: the evolution of the at-home self-injection approach
{{output}}
Purpose of review: New biological agents, in addition to the well-established omalizumab, have been nowadays introduced into clinical practice for severe asthma. This suggested the possibility of an at-home self-administration, a... ...
